Otolanum AG
Records under this name other than the patents Otolanum AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Otolanum AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,728,015 | Compositions for Weight Management Term ended Term ended Aug 2, 2025 · High confidence | Term ended | Term ended Aug 2, 2025 | High confidence |
| US 7,737,165 | Methods of Reducing Weight Gain Associated with Olanzapine Treatment Term ended Ended no later than Apr 21, 2025 · Medium confidence | Term ended | Ended no later than Apr 21, 2025 | Medium confidence |
| US 10,709,682 | Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system Lapsed on the fee record Ended Jul 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2024 | From the USPTO record |
| US 8,642,631 | Methods of treating mammals with eustachian tube dysfunctions Lapsed on the fee record Ended Feb 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2022 | From the USPTO record |